
Alyeska Investment Group’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $98.4M | Buy |
+530,129
| New | +$98.4M | 0.35% | 79 |
|
2025
Q1 | – | Sell |
-12,957
| Closed | -$2.3M | – | 492 |
|
2024
Q4 | $2.3M | Buy |
+12,957
| New | +$2.3M | 0.01% | 456 |
|
2023
Q2 | – | Sell |
-731,371
| Closed | -$117M | – | 462 |
|
2023
Q1 | $117M | Buy |
+731,371
| New | +$117M | 1.02% | 12 |
|
2020
Q2 | – | Sell |
-193,474
| Closed | -$14.7M | – | 439 |
|
2020
Q1 | $14.7M | Sell |
193,474
-370,536
| -66% | -$28.2M | 0.29% | 101 |
|
2019
Q4 | $49.9M | Sell |
564,010
-193,545
| -26% | -$17.1M | 0.66% | 50 |
|
2019
Q3 | $57.4M | Buy |
+757,555
| New | +$57.4M | 0.83% | 28 |
|
2017
Q4 | – | Sell |
-19,294
| Closed | -$1.71M | – | 385 |
|
2017
Q3 | $1.71M | Sell |
19,294
-1,752,601
| -99% | -$156M | 0.01% | 351 |
|
2017
Q2 | $128M | Buy |
+1,771,895
| New | +$128M | 1.07% | 9 |
|
2015
Q1 | – | Sell |
-13,516
| Closed | -$884K | – | 461 |
|
2014
Q4 | $884K | Buy |
+13,516
| New | +$884K | 0.02% | 390 |
|
2014
Q1 | – | Sell |
-235,000
| Closed | -$12.4M | – | 265 |
|
2013
Q4 | $12.4M | Buy |
+235,000
| New | +$12.4M | 0.49% | 58 |
|